Autoimmune diseases Aldosterone Biomarqueurs Anti-IgE IgG Acid-alpha-glucosidase Mass cytometry Anti‐mitochondrial antibodies Immune checkpoint inhibitors Polymyositis Muscle Anti-MDA5 autoantibodies Anémie hémolytique IBM Adult Autoantibody Antiphospholipid syndrome Biomarker Male Humans Dermatomyositis Fabry disease Biomarkers AAV antibody Autoimmunity Inflammatory myopathy Anticorps anti-agalsidase AAV Agalsidase Abnormal movement Active Adolescence Female Dependovirus/genetics/immunology Auto‐antibodies Anti-synthetase syndrome Myocarditis Analyses multidimensionnelles Anti-Mi2 Inclusion body myositis Anti-drug antibodies Skeletal muscle Aldostérone Cardio-oncology Case reports IMNM Animals Systems biology Machine learning Acute Kidney Injury/epidemiology/etiology Deep immune profiling Antisynthetase syndrome Antisynthetase Immunotherapy COVID-19 Cytokines Adjudication DM Amyotrophy Antibodies AAV vectors Pharmacology Middle Aged Auto-immunité Anti-agalsidase antibodies Antibody responses Myositis and muscle disease Autoantibodies Adeno-associated virus Prognosis Biopsy Auto-antibodies Interstitial lung disease Sphingosine-1-phosphate Gene therapy Anticorps spécifique des myosites Inflammation Multidisciplinarity Lysosomal storage diseases Amyotrophic lateral sclerosis Outcome measures Aged Bioelectrical impedance analysis AAV humoral immunity Anti-interleukin-6 Arthritis Interferon Adeno-associated virus vector Assisted communication devices Inborn errors of metabolism B-lymphocyte Adeno-associated vector Idiopathic inflammatory myopathies Data integration Myositis Myopathy Cancer AAV vector B cell homeostasis Adverse drug reactions Antisynthétase